For example, aspirin has been shown to sensitise CRC cells with oncogenic PIK3CA mutations to ferroptosis by inhibiting AKT/mTOR signalling, demonstrating promising therapeutic potential.6 Here, PIK3CA is linked to colorectal carcinoma.